Estrella Immunopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Estrella Immunopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q1 2024.
  • Estrella Immunopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2024 was 35.5M shares, a 10431% increase year-over-year.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 35.5M +35.2M +10431% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 35.2M +35M +20759% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 1.05M +969K +1153% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q1 2023 337K -1.08M -76.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 169K -1.01M -85.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 84K -1.2M -93.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 1.42M +420K +42% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 1.42M +420K +42% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 1.18M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-29
Q3 2021 1.28M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 1M Jan 6, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.